Drug Shortage Report for PROTAMINE SULFATE INJECTION, USP
Report ID | 133511 |
Drug Identification Number | 02139537 |
Brand name | PROTAMINE SULFATE INJECTION, USP |
Common or Proper name | Sulfate de protamine injectable, USP 10 mg/mL, fiole DU, 25 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | PROTAMINE SULFATE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25 mL |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-02-02 |
Actual start date | 2021-02-02 |
Estimated end date | 2021-04-12 |
Actual end date | 2021-04-12 |
Shortage status | Resolved |
Updated date | 2021-04-13 |
Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that both sizes of our Protamine Sulfate Injection, USP have been removed from allocation as of Monday, April 12, 2021. The products will be available to all customers through all distribution channels without any volume restrictions. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2021-04-13 | English | Compare |
v6 | 2021-04-09 | French | Compare |
v5 | 2021-04-09 | English | Compare |
v4 | 2021-04-09 | French | Compare |
v3 | 2021-04-09 | English | Compare |
v2 | 2021-02-05 | French | Compare |
v1 | 2021-02-05 | English | Compare |
Showing 1 to 7 of 7